ARF Flashcards

(47 cards)

1
Q
  • multisystem disease resulting from an autoimmune reaction to infection with GAS
  • cardiac valvular damage (rheumatic heart disease [RHD]), which may persist after the other features have disappeared
A

ARF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GLOBAL CONSIDERATIONS

A
  • ARF and RHD are diseases of poverty
  • RHD is the most common cause of heart disease in children in developing countries
  • major cause of mortality and morbidity in adults
  • 95% of ARF cases and RHD deaths now occur in developing countries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • ARF is mainly a disease of children age
  • peaks between
A
  • 5-14 years
  • 25 and 40 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ARF is exclusively caused by infection of the upper respiratory tract
with

A

GAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

appear to be associated with susceptibility

A

HLA-DR7 and HLA-DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

class I] alleles have been associated with protection

A
  • HLA-DRS,
  • HLA-DR6,
  • HLA-DR51,
  • HLA-DR5S2,
  • HLA-DQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Associations have also been described with polymorphisms at the ___, high levels of circulating mannose-binding lectin, and Toll-like receptors

A

tumor necrosis factor a locus (TNF a-308 and TNF-a-238)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

latent period of ARF

A

3 week (1-5 weeks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical Features of ARF

A
  • Polyarthritis (60-75%)
  • carditis (50-60%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Erythema marginatum and subcutaneous nodules are now rare, being found in

A

<5% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Up to 75% of patients with ARF progress to

A

RHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hallmark of rheumatic carditis

A

Valvular damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

is almost always affected

A

mitral valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

characteristic manifestation of carditis in previously
unaffected individuals is ____, sometimes
accompanied by ____

A
  • mitral regurgitation
  • aortic regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

WHF Criteria for Echocardiographic Dx of RHD in Individuals <20 y.o

DEFINITE RHD

A
  • Pathologic MR and at least two morphologic features of RHD of the mitral valve
  • MS mean gradient 4 mmHg (note: congenital MV anomalies must be
    excluced)
  • Pathologic AR and at least two morphologic features of RHD of the AV note: bicuspid AV and dilated aortic root must be excluded
  • Borderline disease of both the MV and AV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WHF Criteria for Echocardiographic Dx of RHD in Individuals <20 y.o

BORDERLINE RHD

A
  • At least two morphologic features Of RHD of the MV without pathologic MR or MS
  • Pathologic MR
  • Patholorgic AR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

WHF Criteria for Echocardiographic Dx of RHD in Individuals <20 y.o

NORMAL ECHOCARDIOGRAPHIC FINDINGS

A

ALL 4

  • MR that does not meet all 4 Doppler criteria (physiologic MR)
  • AR that does not meet all 4 Doppler criteria (physiologic AR)
  • An isolated morphologic feature of RHD of the MV (e.g valvular thickening without any associated pathologic stenosis or regurgitation
  • Morphologic feature of RMD of the AV (e.g valvular thickening) w/o any associated Pathologic Stenosis or regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

most common form of joint involvement in ARF

A

Arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  • migratory, moving from one joint to another over a period of hours
  • ARF almost always affects the large joints
  • most commonly the knees, ankles, hips, and elbows—and is
    asymmetric
A

Polyarthritis

20
Q

commonly occurs in the absence of other manifestations

A

Sydenham’s chorea

21
Q
  • follows a prolonged latent period after group A streptococcal infection
  • found mainly in females
  • The choreiform movements affect particularly the head (causing characteristic darting movements of the tongue) and the upper limbs
  • More than 50% of patients presenting with chorea will have carditis, for which reason echocardiography should be part of the workup
22
Q

classic rash of ARF

A

erythema marginatum

23
Q

painless, small (0.5—2 cm), mobile lumps beneath the skin
overlying bony prominences

A

Subcutaneous nodules

24
Q

The most common serologic tests for Evidence of a preceding GAS infection

A
  • anti-streptolysin O (ASO)
  • anti-DNase B (ADB) titers
25
Diagnosis: initial ARF
2 major manifestations or 1 major plus 2 minor manifestations
26
Diagnosis: recurrent ARF
2 major or 1 major and 2 minor or 3 major
27
Major Criteria
- Low-risk populations + Carditis - Clinical and/or subclinical + Arthritis - Polyarthritis only + Chorea + Erythema marginatum + SC nodules
28
Minor Criteria
- Low-risk populations + Polyarthralgia + Fever (238.5°C) + ESR =60 mm in the first hour and/or CRP 23.0 ma/dl + Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion)
29
Test to Always request :
- Electrocardiogram (ECG) - Echocardiogram - Complete blood count (CBC) - C-reactive protein (CRP) - Streptococcal serology (antistreptolysin and anti-DNase B)
30
Tests to exclude alternative diagnoses, depending on clinical presentation and locally endemic infections for Neisseria gonorrhoeae
Urine molecular test
31
Tests to exclude alternative diagnoses, depending on clinical presentation and locally endemic infections Chlamydia trachomatis
Urine molecular test
32
Tests to exclude alternative diagnoses, depending on clinical presentation and locally endemic infections for viral hepatitis, Yersinia spp., cytomegalovirus (CMV), parvovirus 819, respiratory viruses, Ross River virus, Barmah Forest virus
Serologic or other testing
33
is the drug of choice for ARF
Penicillin
34
- no proven value in the treatment of carditis or chorea - At higher doses, the patient should be monitored for symptoms such as nausea, vomiting, or tinnitus
SALICYLATES AND NSAIDs
35
Drug of choice for Carditis or chorea
Aspirin
36
Is a suitable alternative to aspirin and has the advantage of twice-daily dosing
Naproxen
37
In patients with severe chorea, ___ is preferred to haloperidol.
carbamazepine or sodium valproate
38
Are effective and lead to more rapid symptom reduction in chorea. They should be considered in severe or refractory cases.
corticosteroids
39
Untreated, ARF lasts on average
12 weeks
40
With treatment, patients are usually discharged from hospital within
1-2 weeks
41
inflammatory markers should be monitored every
1-2 weeks until they have normalized (usually within 4-6 weeks)
42
should be performed after 1 month to determine if there has been progression of carditis.
echocardiogram
43
if commenced within 9 days of sore throat onset, a course of ___ will prevent almost all cases of ARF that would otherwise have developed.
penicillin
44
SECONDARY PREVENTION - best antibiotic for secondary prophylaxis - can be given every 3 weeks, or even every 2 weeks, to persons considered to be at particularly high risk
benzathine penicillin G
45
AHA Recommendations for Duration of Secondary Prophylaxis CATERGORY OF PX - Rheumatic fever without carditis
For 5 years after the last attack or 21 years of age (whichever is longer)
46
AHA Recommendations for Duration of Secondary Prophylaxis CATERGORY OF PX - Rheumatic fever with carditis but no residual valvular disease
For 10 years after the last attack, or 21 y.o (whichever is longer)
47
AHA Recommendations for Duration of Secondary Prophylaxis CATERGORY OF PX - Rheumatic fever with persistent valvular disease, evident clinically or On echocardiography
For 10 years after the last attack, or 40 years of age (whichever is longer); Sometimes lifelong prophylaxis